ATI Physical Therapy, Inc.
ATIP · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.00 | 0.02 | -0.00 |
| FCF Yield | 61.99% | -26.98% | 41.17% | -177.04% |
| EV / EBITDA | 40.48 | -81.06 | 22.87 | 35.38 |
| Quality | ||||
| ROIC | -0.12% | 0.12% | 0.73% | -0.45% |
| Gross Margin | 13.74% | 13.17% | 15.97% | 13.31% |
| Cash Conversion Ratio | -2.41 | 0.10 | -3.00 | 2.67 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.81% | 5.62% | 4.90% | 4.09% |
| Free Cash Flow Growth | 193.42% | -187.48% | 119.63% | -1,657.97% |
| Safety | ||||
| Net Debt / EBITDA | 39.89 | -78.29 | 22.26 | 34.29 |
| Interest Coverage | -0.05 | 0.08 | 0.46 | -0.30 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 38.12 | 49.65 | 55.54 | 57.86 |